Robert Rolfe1,2, Charles Kwobah3, Florida Muro4, Anushka Ruwanpathirana5, Furaha Lyamuya4, Champica Bodinayake6,7, Ajith Nagahawatte6,7, Bhagya Piyasiri8, Tianchen Sheng6, John Bollinger6, Chi Zhang6, Truls Ostbye6, Shamim Ali3, Richard Drew9,10, Peter Kussin6, Deverick J Anderson9,11, Christopher W Woods9,6, Melissa H Watt12, Blandina T Mmbaga6,4,13, L Gayani Tillekeratne9,6,7. 1. Duke University, Durham, NC, USA. Robert.rolfe@duke.edu. 2. Duke Global Health Institute, Durham, NC, USA. Robert.rolfe@duke.edu. 3. Moi University/Moi Teaching and Referral Hospital, Eldoret, Kenya. 4. Kilimanjaro Christian Medical University College, Moshi, Tanzania. 5. Colombo Teaching Hospital North, Ragama, Sri Lanka. 6. Duke Global Health Institute, Durham, NC, USA. 7. University of Ruhuna, Galle, Sri Lanka. 8. Teaching Hospital Karapitiya, Galle, Sri Lanka. 9. Duke University, Durham, NC, USA. 10. Campbell University College of Pharmacy and Health Sciences, Buies Creek, NC, USA. 11. Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC, USA. 12. University of Utah, Salt Lake City, UT, USA. 13. Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Abstract
BACKGROUND: Antimicrobial resistance has been named as one of the top ten threats to public health in the world. Hospital-based antimicrobial stewardship programs (ASPs) can help reduce antimicrobial resistance. The purpose of this study was to determine perceived barriers to the development and implementation of ASPs in tertiary care centers in three low- and middle-income countries (LMICs). METHODS: Interviews were conducted with 45 physicians at tertiary care hospitals in Sri Lanka (n = 22), Kenya (12), and Tanzania (11). Interviews assessed knowledge of antimicrobial resistance and ASPs, current antimicrobial prescribing practices, access to diagnostics that inform antimicrobial use, receptiveness to ASPs, and perceived barriers to implementing ASPs. Two independent reviewers coded the interviews using principles of applied thematic analysis, and comparisons of themes were made across the three sites. RESULTS: Barriers to improving antimicrobial prescribing included prohibitively expensive antimicrobials, limited antimicrobial availability, resistance to changing current practices regarding antimicrobial prescribing, and limited diagnostic capabilities. The most frequent of these barriers in all three locations was limited drug availability. Many physicians in all three sites had not heard of ASPs before the interviews. Improved education was a suggested component of ASPs at all three sites. The creation of guidelines was also recommended, without prompting, by interviewees at all three sites. Although most participants felt microbiological results were helpful in tailoring antibiotic courses, some expressed distrust of laboratory culture results. Biomarkers like erythrocyte sedimentation rate and c-reactive protein were not felt to be specific enough to guide antimicrobial therapy. Despite limited or no prior knowledge of ASPs, most interviewees were receptive to implementing protocols that would include documentation and consultation with ASPs regarding antimicrobial prescribing. CONCLUSIONS: Our study highlighted several important barriers to implementing ASPs that were shared between three tertiary care centers in LMICs. Improving drug availability, enhancing availability of and trust in microbiologic data, creating local guidelines, and providing education to physicians regarding antimicrobial prescribing are important steps that could be taken by ASPs in these facilities.
BACKGROUND: Antimicrobial resistance has been named as one of the top ten threats to public health in the world. Hospital-based antimicrobial stewardship programs (ASPs) can help reduce antimicrobial resistance. The purpose of this study was to determine perceived barriers to the development and implementation of ASPs in tertiary care centers in three low- and middle-income countries (LMICs). METHODS: Interviews were conducted with 45 physicians at tertiary care hospitals in Sri Lanka (n = 22), Kenya (12), and Tanzania (11). Interviews assessed knowledge of antimicrobial resistance and ASPs, current antimicrobial prescribing practices, access to diagnostics that inform antimicrobial use, receptiveness to ASPs, and perceived barriers to implementing ASPs. Two independent reviewers coded the interviews using principles of applied thematic analysis, and comparisons of themes were made across the three sites. RESULTS: Barriers to improving antimicrobial prescribing included prohibitively expensive antimicrobials, limited antimicrobial availability, resistance to changing current practices regarding antimicrobial prescribing, and limited diagnostic capabilities. The most frequent of these barriers in all three locations was limited drug availability. Many physicians in all three sites had not heard of ASPs before the interviews. Improved education was a suggested component of ASPs at all three sites. The creation of guidelines was also recommended, without prompting, by interviewees at all three sites. Although most participants felt microbiological results were helpful in tailoring antibiotic courses, some expressed distrust of laboratory culture results. Biomarkers like erythrocyte sedimentation rate and c-reactive protein were not felt to be specific enough to guide antimicrobial therapy. Despite limited or no prior knowledge of ASPs, most interviewees were receptive to implementing protocols that would include documentation and consultation with ASPs regarding antimicrobial prescribing. CONCLUSIONS: Our study highlighted several important barriers to implementing ASPs that were shared between three tertiary care centers in LMICs. Improving drug availability, enhancing availability of and trust in microbiologic data, creating local guidelines, and providing education to physicians regarding antimicrobial prescribing are important steps that could be taken by ASPs in these facilities.
Entities:
Keywords:
Antimicrobial Stewardship; Low- and middle-income countries; Qualitative analysis
Authors: Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton Journal: Clin Infect Dis Date: 2006-12-13 Impact factor: 9.079
Authors: Thais C de Oliveira; Priscila T Rodrigues; Maria José Menezes; Raquel M Gonçalves-Lopes; Melissa S Bastos; Nathália F Lima; Susana Barbosa; Alexandra L Gerber; Guilherme Loss de Morais; Luisa Berná; Jody Phelan; Carlos Robello; Ana Tereza R de Vasconcelos; João Marcelo P Alves; Marcelo U Ferreira Journal: PLoS Negl Trop Dis Date: 2017-07-31
Authors: Angela Huttner; Stephan Harbarth; Jean Carlet; Sara Cosgrove; Herman Goossens; Alison Holmes; Vincent Jarlier; Andreas Voss; Didier Pittet Journal: Antimicrob Resist Infect Control Date: 2013-11-18 Impact factor: 4.887
Authors: Sachiko Ozawa; Daniel R Evans; Sophia Bessias; Deson G Haynie; Tatenda T Yemeke; Sarah K Laing; James E Herrington Journal: JAMA Netw Open Date: 2018-08-03
Authors: Florida J Muro; Furaha S Lyamuya; Charles Kwobah; John Bollinger; Champica K Bodinayake; Ajith Nagahawatte; Bhagya Piyasiri; Ruvini Kurukulasooriya; Shamim Ali; Rose Mallya; Robert Rolfe; Anushka Ruwanpathirana; Tianchen Sheng; Truls Østbye; Richard Drew; Peter Kussin; Christopher W Woods; Deverick J Anderson; Blandina T Mmbaga; L Gayani Tillekeratne Journal: Front Public Health Date: 2022-04-25